{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:11:13Z","timestamp":1783627873382,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T00:00:00Z","timestamp":1517529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Medical Specialty Fund Projects of Shanghai","award":["ZK2015A07"],"award-info":[{"award-number":["ZK2015A07"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China (NSFC)","doi-asserted-by":"crossref","award":["81502267"],"award-info":[{"award-number":["81502267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Youth Fundation of Zhongshan Hospital","award":["2016ZSQZ54"],"award-info":[{"award-number":["2016ZSQZ54"]}]},{"name":"General Scientific Research foundation of Shanghai Mental Health Center","award":["2017-YJ-10"],"award-info":[{"award-number":["2017-YJ-10"]}]},{"name":"General Scientific Research foundation of Shanghai Mental Health Center","award":["Shanghai Science and Techology Committee Funding"],"award-info":[{"award-number":["Shanghai Science and Techology Committee Funding"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jbo.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,2,3]],"date-time":"2018-02-03T18:17:54Z","timestamp":1517681874000},"page":"38-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data"],"prefix":"10.1016","volume":"11","author":[{"given":"Hongwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Biskup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weige","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1103-5914","authenticated-orcid":false,"given":"Guangfu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"7","key":"10.1016\/j.jbo.2018.01.004_bib2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(13)70567-9","article-title":"Breast cancer in China","volume":"15","author":"Fan","year":"2014","journal-title":"Lancet Oncol."},{"issue":"30","key":"10.1016\/j.jbo.2018.01.004_bib3","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1200\/JCO.2010.32.6462","article-title":"Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics","volume":"29","author":"Colzani","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/cancers7020815","article-title":"Effects of age on the detection and management of breast cancer","volume":"7","author":"McGuire","year":"2015","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.jbo.2018.01.004_bib5","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/ijc.30015","article-title":"Adherence to the world cancer research fund\/american institute for cancer research recommendations and breast cancer risk","volume":"138","author":"Harris","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-008-9990-8","article-title":"Lifestyle changes and breast cancer prognosis: a review","volume":"114","author":"Kellen","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10555-016-9636-y","article-title":"Current challenges of metastatic breast cancer","volume":"35","author":"Lim","year":"2016","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jbo.2018.01.004_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.breast.2016.06.024","article-title":"Over-treatment in metastatic breast cancer","volume":"31","author":"Senkus","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.jbo.2018.01.004_bib9","first-page":"87","article-title":"Estimated number of prevalent cases of metastatic bone disease in the us adult population","volume":"4","author":"Li","year":"2012","journal-title":"Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.jbo.2018.01.004_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbo.2018.01.004_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-6-179","article-title":"Clinical management of women with metastatic breast cancer: a descriptive study according to age group","volume":"6","author":"Manders","year":"2006","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.canep.2014.05.005","article-title":"Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients","volume":"38","author":"Harries","year":"2014","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.jbo.2018.01.004_bib13","first-page":"97","article-title":"Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark","volume":"5","author":"Svendsen","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"28","key":"10.1016\/j.jbo.2018.01.004_bib14","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1200\/JCO.2007.11.8604","article-title":"Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases","volume":"25","author":"Lipton","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"35","key":"10.1016\/j.jbo.2018.01.004_bib15","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcms.2010.11.001","article-title":"Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias","volume":"39","author":"Knobloch","year":"2011","journal-title":"J. Craniomaxillofac Surg."},{"issue":"11","key":"10.1016\/j.jbo.2018.01.004_bib17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.jbo.2018.01.004_bib18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.jbo.2018.01.004_bib19","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1182\/blood-2010-03-276683","article-title":"Association between red blood cell transfusions and development of non-Hodgkin lym- phoma: a meta-analysis of observational studies","volume":"116","author":"Castillo","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jbo.2018.01.004_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10549-016-3782-3","article-title":"The incidence of bone metastasis after early-stage breast cancer in Canada","volume":"156","author":"Liede","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib21","doi-asserted-by":"crossref","first-page":"e007702","DOI":"10.1136\/bmjopen-2015-007702","article-title":"Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval","volume":"5","author":"Cetin","year":"2015","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib22","first-page":"43","article-title":"Bone fracture in breast cancer patients with isolated bone metastasis","volume":"110","author":"Dibekoglu","year":"2015","journal-title":"Chirugia"},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10585-014-9685-y","article-title":"Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases","volume":"32","author":"Bollen","year":"2015","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.jbo.2018.01.004_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13014-015-0458-9","article-title":"Prognostic factors for survival of women with unstable spinal bone metastases from breast cancer","volume":"10","author":"Foerster","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.canep.2014.05.005","article-title":"Incidence of bone metastases and survival after a diagnosis of bone metastases in breast cancer patients","volume":"38","author":"Harries","year":"2014","journal-title":"Cancer Epidemiol."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jbo.2014.05.001","article-title":"Bone metastases in breast cancer: frequency, metastatic pattern and non-systemic locoregional therapy","volume":"3","author":"Steinauer","year":"2014","journal-title":"J. Bone Oncol."},{"issue":"5","key":"10.1016\/j.jbo.2018.01.004_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10147-013-0643-5","article-title":"Prevalence and risk factors of bone metastasis and skeletal related events in patients with primary breast cancer in Japan","volume":"19","author":"Yamashiro","year":"2014","journal-title":"Int J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jbo.2018.01.004_bib28","first-page":"2629","article-title":"A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in Turkey","volume":"22","author":"Arican","year":"2014","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jbo.2013.09.001","article-title":"Incidence, consequences and treatment of bone metastases in breast cancer patients - experience from a single cancer centre","volume":"2","author":"Kuchuk","year":"2013","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11596-013-1083-1","article-title":"Analysis of clinicopathological factors associated with bone metastasis in breast cancer","volume":"33","author":"Chen","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"5","key":"10.1016\/j.jbo.2018.01.004_bib31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.3349\/ymj.2013.54.5.1168","article-title":"Prognostic factors for patients with bone-only metastasis in breast cancer","volume":"54","author":"Ahn","year":"2013","journal-title":"Yonsei Med. J."},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-011-1721-x","article-title":"Mortality following bone metastasis and skeletal-related events among women with breast cancer: a population-based analysis of U.S. Medicare beneficiaries, 1999\u20132006","volume":"131","author":"Sathiakumar","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1634\/theoncologist.2010-0350","article-title":"Treatment outcome and prognostic factors for patients with bone-only metastases of breast cancer: a single-institution retrospective analysis","volume":"16","author":"Niikura","year":"2011","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4143\/crt.2011.43.2.89","article-title":"Implications of bone-only metastases in breast cancer: favorable preference with excellent outcomes of hormone receptor positive breast cancer","volume":"43","author":"Lee","year":"2011","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.jbo.2018.01.004_bib35","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-10-381","article-title":"An open cohort study of bone metastasis incidence following surgery in breast cancer patients","volume":"10","author":"Koizumi","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib36","first-page":"197","article-title":"Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting","volume":"18","author":"Trinkaus","year":"2010","journal-title":"Support Care Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib37","first-page":"178","article-title":"Factors associated with bone metastasis in breast cancer: a preliminary study in an Indonesian population","volume":"40","author":"Irawan","year":"2008","journal-title":"Acta Med. Indones."},{"issue":"6","key":"10.1016\/j.jbo.2018.01.004_bib38","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/030089160709300611","article-title":"Factors affecting survival in breast cancer patients following bone metastasis","volume":"93","author":"Yavas","year":"2007","journal-title":"Tumori"},{"issue":"5\u20136","key":"10.1016\/j.jbo.2018.01.004_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000107772","article-title":"Diagnosis, management and clinical outcome of bone metastases in breast cancer patients: results from a prospective, multicenter study","volume":"71","author":"Cazzaniga","year":"2006","journal-title":"Oncology"},{"issue":"7","key":"10.1016\/j.jbo.2018.01.004_bib40","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/cncr.20545","article-title":"Metastatic breast carcinoma confined to bone: portrait of a clinical entity","volume":"101","author":"Briasoulis","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib41","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.bjc.6601198","article-title":"Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features","volume":"89","author":"James","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0959-8049(99)00331-7","article-title":"Risk of complications from bone metastases in breast cancer. implications for management","volume":"36","author":"Plunkett","year":"2000","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1097-0142(20000715)89:2<363::AID-CNCR22>3.0.CO;2-3","article-title":"Predictors of skeletal complications in patients with metastatic breast carcinoma","volume":"89","author":"Domchek","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2018.01.004_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1741-7015-11-151","article-title":"Genetic heterogeneity in breast cancer: the road to personalized medicine?","volume":"11","author":"Baird","year":"2013","journal-title":"BMC Med."},{"issue":"20 Pt 2","key":"10.1016\/j.jbo.2018.01.004_bib45","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"Br. J. Cancer"},{"issue":"9606","key":"10.1016\/j.jbo.2018.01.004_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(08)60069-0","article-title":"Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials","volume":"371","author":"Group EBCTC","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib48","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdr397","article-title":"Imaging bone metastases in breast cancer: evidence on comparative test accuracy","volume":"23","author":"Houssami","year":"2012","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2018.01.004_bib49","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-014-3046-z","article-title":"Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival","volume":"46","author":"van der Pol","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.jbo.2018.01.004_bib50","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/ERC-09-0012","article-title":"Mechanisms of bone metastases of breast cancer","volume":"16","author":"Suva","year":"2009","journal-title":"Endocr. Relat. Cancer"},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","article-title":"Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors","volume":"29","author":"Casimiro","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"issue":"22","key":"10.1016\/j.jbo.2018.01.004_bib52","first-page":"5463","article-title":"Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive","volume":"118","author":"Lin","year":"2012","journal-title":"Cancer Netw., Cancer"},{"issue":"16","key":"10.1016\/j.jbo.2018.01.004_bib53","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.1979.03300160027019","article-title":"Bone metastases and bone pain in breast cancer. Are they closely associated?","volume":"242","author":"Front","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib54","first-page":"15","article-title":"Pathophysiology of bone cancer pain","volume":"3","author":"Sabino","year":"2005","journal-title":"J. Support Oncol."},{"issue":"11","key":"10.1016\/j.jbo.2018.01.004_bib55","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jbo.2018.01.004_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474086.2013.874943","article-title":"Management of bone disease in multiple myeloma","volume":"7","author":"Terpos","year":"2014","journal-title":"Expert Rev. Hematol."},{"issue":"9","key":"10.1016\/j.jbo.2018.01.004_bib57","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","article-title":"American Society of Clinical O. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"Van Poznak","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clon.2012.10.010","article-title":"Bisphosphonates in the adjuvant treatment of breast cancer","volume":"25","author":"Winter","year":"2013","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"2","key":"10.1016\/j.jbo.2018.01.004_bib59","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/annonc\/mds277","article-title":"Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results","volume":"24","author":"Coleman","year":"2013","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.jbo.2018.01.004_bib60","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1055\/s-0035-1546151","article-title":"Bone-Targeted Therapy","volume":"75","author":"Salmen","year":"2015","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3816\/CBC.2010.n.034","article-title":"Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer","volume":"10","author":"Delea","year":"2010","journal-title":"Clin. Breast Cancer"},{"issue":"4","key":"10.1016\/j.jbo.2018.01.004_bib62","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jval.2010.11.014","article-title":"Hospital resource utilization and treatment cost of skeletal-related events in patients with metastatic breast or prostate cancer: estimation for the Portuguese National Health System","volume":"14","author":"Felix","year":"2011","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jbo.2018.01.004_bib63","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","article-title":"Practical guidance for the management of aromatase inhibitor-associated bone loss","volume":"19","author":"Hadji","year":"2008","journal-title":"Ann. Oncol."},{"issue":"20","key":"10.1016\/j.jbo.2018.01.004_bib64","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-08-1572","article-title":"Advancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference","volume":"14","author":"Coleman","year":"2008","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137417301446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137417301446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:16:41Z","timestamp":1761941801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137417301446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":64,"alternative-id":["S2212137417301446"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2018.01.004","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence, risk factors and prognostic characteristics of bone metastases and skeletal-related events (SREs) in breast cancer patients: A systematic review of the real world data","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}